Vaccine News and Research

Latest Vaccine News and Research

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality infectious disease antigens and antibodies.

9 Jul 2020

Measuring the medical impact of COVID-19

The Great Chinese Famine (1959-1962) was probably the greatest man-made disaster in history resulting in tens of millions of deaths.

9 Jul 2020

Shingles vaccination rate soars but leaves many behind

Worried about the high cost of the copayment for the shingles vaccine, Jacky Felder, a Medicare beneficiary, opted against getting immunized last year.

9 Jul 2020

Research shows how SARS-CoV-2 alters translation

Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5’ end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.

9 Jul 2020

Facebook allows public to gain stronger voice against the use of HPV vaccine

One of the biggest social media sites -- Facebook -- has allowed "anti-vaxxers" to gain a stronger voice against the use of the human papillomavirus, or HPV, vaccine, according to a new study from a media expert at the University of Missouri.

9 Jul 2020

Researchers map RNA structure throughout SARS-CoV-2 genome

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is currently at the heart of a pandemic that has cost the world more than 550,000 lives, 12 million infections, and uncounted years of productivity, is an RNA virus with the largest genome among all such viruses. This 30 kb size virus has caused many difficulties for scientists in search of a vaccine.

9 Jul 2020

Researchers propose novel approach to limit life-threatening complications related to COVID-19

Patients with severe COVID-19 frequently experience a life-threatening immune reaction, sometimes called a cytokine storm, which can lead to respiratory failure, organ damage and potentially death.

8 Jul 2020

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

A recent 'tour-de-force' research endeavor, led by scientists from Harvard University, explored the propensity of a biomaterial vaccine based on mesoporous silica rods to spawn highly protective humoral responses against relevant antigens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Jul 2020

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

8 Jul 2020

Tuberculosis vaccine may play a significant role in mitigating COVID-19 mortality rates

One of the emerging questions about the coronavirus that scientists are working to understand is why developing countries are showing markedly lower rates of mortality in COVID-19 cases than expected.

8 Jul 2020

Fred Hutch joins new clinical trials network to fight COVID-19

Fred Hutchinson Cancer Research Center has been named the coordinating center for vaccine clinical trials of the COVID-19 Prevention Network.

8 Jul 2020

Researchers isolate potent SARS-CoV-2 neutralizing antibodies

An important line of defense in the fight against the new coronavirus SARS-CoV-2 is the formation of neutralizing antibodies.

8 Jul 2020

ACS publishes updated guideline for HPV vaccination

The American Cancer Society has updated its guideline for HPV vaccination, adapting a 2019 update from the Federal Advisory Committee on Immunization Practices.

8 Jul 2020

Analysis: How a COVID-19 vaccine could cost Americans dearly

Yes, of course, Americans' health is priceless, and reining in a deadly virus that has trashed the economy would be invaluable.

8 Jul 2020

World's first clinical trial of immune-boosting strategy to protect cancer patients from COVID-19

In the race to find new ways to prevent and treat COVID-19, Canadian researchers have launched an innovative clinical trial focussed on strengthening the immune system for one of the most vulnerable populations - cancer patients.

8 Jul 2020

China reports Dengue fever after bubonic plague threat

The actively spreading coronavirus disease (COVID-19) first emerged in China in December 2019. More than six months after, the world grapples with nearly 11.8 confirmed cases of the viral infection. Now, as China slowly starts to reboot its economy and ease lockdown restrictions, two new health issues are emerging.

8 Jul 2020

Study of glycosylation on SARS-CoV-2 spike protein

The first intimation of the current COVID-19 crisis came with the news of severe pneumonic illness caused by an unknown agent in a Chinese city called Wuhan, issued on the last day of 2019. Following this, researchers found the cause to be a novel coronavirus, closely related to the earlier SARS virus, now called severe acute respiratory syndrome coronavirus 2.

8 Jul 2020

Many in the UK would refuse a coronavirus vaccine, survey finds

The novel coronavirus pandemic (COVID-19) has left many scientists and pharmaceutical companies racing to develop an effective vaccine to combat the viral infection. With 21 candidate vaccines in clinical evaluation, 139 candidate vaccines in preclinical evaluation across the world, most countries are hoping to be first to the post.

7 Jul 2020

Coronavirus study shows herd immunity is infeasible

Herd immunity has been one of the key topics amid the coronavirus pandemic. Previous reports show that when a large proportion of the population gets immune to the novel coronavirus, through vaccination, herd immunity can be achieved.

7 Jul 2020

Gene expression networks flag potential therapeutic targets for SARS-CoV-2

An international team of researchers from Canada, Australia, the Netherlands, and the United States has identified dozens of genes that could contribute to the pathology of coronavirus disease 2019 (COVID-19) and serve as potential therapeutic targets.

7 Jul 2020